These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38505614)

  • 1. Depletion of ApoA5 aggravates spontaneous and diet-induced nonalcoholic fatty liver disease by reducing hepatic NR1D1 in hamsters.
    Guo J; Miao G; Zhang W; Shi H; Lai P; Xu Y; Zhang L; Chen G; Han Y; Zhao Y; Liu G; Zhang L; Wang Y; Huang W; Xian X
    Theranostics; 2024; 14(5):2036-2057. PubMed ID: 38505614
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine causes non-alcoholic fatty liver disease via inhibiting the secretion of apolipoprotein A5.
    Li R; Zhu W; Huang P; Ding C; Tang Y; Lian P; Huang X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):730-738. PubMed ID: 35837772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of apolipoprotein A5 in non-alcoholic fatty liver disease.
    Ress C; Moschen AR; Sausgruber N; Tschoner A; Graziadei I; Weiss H; Schgoer W; Ebenbichler CF; Konrad RJ; Patsch JR; Tilg H; Kaser S
    Gut; 2011 Jul; 60(7):985-91. PubMed ID: 21339203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine leads to nonalcoholic fatty liver disease through the apolipoprotein A5 pathway.
    Li R; Zhu W; Huang P; Yang Y; Luo F; Dai W; Shen L; Pei W; Huang X
    Biomed Pharmacother; 2021 Sep; 141():111803. PubMed ID: 34146854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of exons 3 and 4 in the mouse Nr1d1 gene worsens high-fat diet-induced hepatic steatosis.
    Na H; Lee H; Lee MH; Lim HJ; Kim HJ; Jeon Y; Kang HL; Lee MO
    Life Sci; 2016 Dec; 166():13-19. PubMed ID: 27720799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol Diet.
    Svop Jensen V; Fledelius C; Max Wulff E; Lykkesfeldt J; Hvid H
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33673227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue.
    Falkevall A; Mehlem A; Folestad E; Ning FC; Osorio-Conles Ó; Radmann R; de Hollanda A; Wright SD; Scotney P; Nash A; Eriksson U
    J Hepatol; 2023 May; 78(5):901-913. PubMed ID: 36717026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Supplementation with Hazelnut Oil Reduces Serum Hyperlipidemia and Ameliorates the Progression of Nonalcoholic Fatty Liver Disease in Hamsters Fed a High-Cholesterol Diet.
    Lu JH; Hsia K; Lin CH; Chen CC; Yang HY; Lin MH
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31540081
    [No Abstract]   [Full Text] [Related]  

  • 9. Electronegative LDL is linked to high-fat, high-cholesterol diet-induced nonalcoholic steatohepatitis in hamsters.
    Lai YS; Yang TC; Chang PY; Chang SF; Ho SL; Chen HL; Lu SC
    J Nutr Biochem; 2016 Apr; 30():44-52. PubMed ID: 27012620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
    Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
    J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent restraint-induced sympathetic activation attenuates hepatic steatosis and inflammation in a high-fat diet-fed mouse model.
    Lee SB; Kim HG; Lee JS; Kim WY; Lee MM; Kim YH; Lee JO; Kim HS; Son CG
    Am J Physiol Gastrointest Liver Physiol; 2019 Dec; 317(6):G811-G823. PubMed ID: 31604029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of protective effects of hesperetin and pectolinarigenin on high-fat diet-induced hyperlipidemia and hepatic steatosis in Golden Syrian hamsters.
    Shi L; Zou M; Zhou X; Wang S; Meng W; Lan Z
    Exp Anim; 2023 Feb; 72(1):123-131. PubMed ID: 36310057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake.
    van den Berg SA; Heemskerk MM; Geerling JJ; van Klinken JB; Schaap FG; Bijland S; Berbée JF; van Harmelen VJ; Pronk AC; Schreurs M; Havekes LM; Rensen PC; van Dijk KW
    FASEB J; 2013 Aug; 27(8):3354-62. PubMed ID: 23650188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease.
    Zhang H; Shen Z; Lin Y; Zhang J; Zhang Y; Liu P; Zeng H; Yu M; Chen X; Ning L; Mao X; Cen L; Yu C; Xu C
    J Biol Chem; 2020 Mar; 295(12):3891-3905. PubMed ID: 32051143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice.
    Tanaka Y; Nagoshi T; Takahashi H; Oi Y; Yoshii A; Kimura H; Ito K; Kashiwagi Y; Tanaka TD; Yoshimura M
    Mol Metab; 2022 Jan; 55():101411. PubMed ID: 34863940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
    Chai C; Cox B; Yaish D; Gross D; Rosenberg N; Amblard F; Shemuelian Z; Gefen M; Korach A; Tirosh O; Lanton T; Link H; Tam J; Permyakova A; Ozhan G; Citrin J; Liao H; Tannous M; Hahn M; Axelrod J; Arretxe E; Alonso C; Martinez-Arranz I; Betés PO; Safadi R; Salhab A; Amer J; Tber Z; Mengshetti S; Giladi H; Schinazi RF; Galun E
    Gastroenterology; 2020 Sep; 159(3):999-1014.e9. PubMed ID: 32450149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation.
    Cui CX; Deng JN; Yan L; Liu YY; Fan JY; Mu HN; Sun HY; Wang YH; Han JY
    J Ethnopharmacol; 2017 Aug; 208():24-35. PubMed ID: 28648927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A5 controls fructose-induced metabolic dysregulation in mice.
    Ress C; Dobner J; Rufinatscha K; Staels B; Hofer M; Folie S; Radlinger B; Adolph TE; Rubin EM; Roden M; Tilg H; Kaser S
    Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):972-978. PubMed ID: 33549451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A5: Extracellular and Intracellular Roles in Triglyceride Metabolism.
    Forte TM; Ryan RO
    Curr Drug Targets; 2015; 16(12):1274-80. PubMed ID: 26028042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic accumulation of S-adenosylmethionine in hamsters with non-alcoholic fatty liver disease associated with metabolic syndrome under selenium and vitamin E deficiency.
    Maria Del Bas J; Rodríguez B; Puiggròs F; Mariné S; Rodríguez MA; Moriña D; Armengol L; Caimari A; Arola L
    Clin Sci (Lond); 2019 Feb; 133(3):409-423. PubMed ID: 29122967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.